به جمع مشترکان مگیران بپیوندید!

تنها با پرداخت 70 هزارتومان حق اشتراک سالانه به متن مقالات دسترسی داشته باشید و 100 مقاله را بدون هزینه دیگری دریافت کنید.

برای پرداخت حق اشتراک اگر عضو هستید وارد شوید در غیر این صورت حساب کاربری جدید ایجاد کنید

عضویت

جستجوی مقالات مرتبط با کلیدواژه « escherichia coli » در نشریات گروه « پزشکی »

  • Fatemeh Omidi, Leila Fozouni*, Arash Nikyar, Mehr Ali Mahmood Janlou
    Background

    Cefiderocol is a siderophore cephalosporin with unique cell-penetrating abilities against multidrug-resistant (MDR) Gram-negative bacteria, especially carbapenem-resistant strains. This study aimed to evaluate the prevalence and susceptibility profiles of Cefiderocol on carbapenem-resistant uropathogenic Escherichia coli and Klebsiella pneumoniae isolates among hospitalized patients.

    Methods

    One hundred twenty-nine patients more than 72 h admitted to hospitals participated from Feb. 2021 to Dec. 2022. Urine samples were examined to identify uropathogenic K. pneumoniae and E. coli isolates based on microscopic morphology, cultural and biochemical methods. The carbapenemase production in the isolates was evaluated using modified Hodge tests and PCR. The MIC of Cefiderocol against carbapenemase-producing isolates was evaluated according to CLSI-2021 guidelines.

    Results

    According to phenotypic and genotypic tests, among forty-two E. coli isolates (71.19%) were carbapenemase positive, 38 isolates had the blaOXA gene (90.47%), and among twenty-four K. pneumoniae isolates 96% contained the blaKPC gene. In MIC determination 55.24% of carbapenem-resistant E. coli isolates were inhibited with ≤0.5 μg/ml of Cefiderocol, while only two strains (8.33%) of K. pneumoniae isolates showed resistance to the Cefiderocol (MIC90=2 μg/ml).

    Conclusion

    The present results demonstrate that the emergence of carbapenem-resistant uropathogenic bacteria poses a critical health threat to society. Based on the results, Cefiderocol demonstrated efficacy against carbapenem-resistant clinical isolates at low concentrations.

    Keywords: Cefiderocol, Carbapenemase, Escherichia Coli, Klebsiella Pneumonia
  • Saba Almasi Chegeni, Hossein Esmaeili, Peyman Lotfalizadeh
    Background

    Salivary abomasum disease (SAD) is a devastating disease causing significant mortality in Iranian goat and sheep herds. Understanding the causative agents is essential for developing effective preventive measures. This study investigated the potential role of Shiga toxin-producing Escherichia coli (STEC) in SAD pathogenesis.

    Methods

    We isolated E. coli from kid goats aged 3-30 days experiencing a sudden, acute illness characterized by gait imbalance, and death within 48 hours during the kidding season. Following isolation, we employed multiplex PCR to identify the presence of Shiga toxin genes (Stx1 and Stx2) associated with virulence in STEC strains.

    Results

    E. coli was isolated from 30 (75%) out of 40 animals. Notably, 7 (23.3%) isolates harbored the Stx2 gene, while only one isolate (3.3%) possessed the Stx1 gene.

    Conclusion

    These findings suggest a potential role for STEC, particularly strains carrying the Stx2 gene, in the development of SAD and multiple abomasal hemorrhages, in kid goats. The presence of Shiga toxin genes in a significant proportion of E. coli isolates highlights the importance of further research to elucidate their  contribution to SAD pathogenesis and inform the development of targeted interventions.

    Keywords: Escherichia Coli, Goat, Salivary Abomasumdisease, Shiga Toxin
  • Hadi Sedigh Ebrahim-Saraie, Mohammadesmaeil Amini, Meysam Hasannejad-Bibalan, Ervin Zadgari, Arash Bakhshi
    Background

    Biological contamination of foods is a serious problem for human health. Animal and animal products may be contaminated by these biological and chemical contaminants. One of the most important causes of foodborne illness in humans is Escherichia coli. Fluoroquinolones can be used as a suitable treatment for enteric infections in food-producing livestock. We aimed to evaluate the current status of resistance of E. coli strains isolated from animals and animal products to fluoroquinolone in Iran.

    Methods

     A systematic search was conducted using the Web of Science, PubMed, Embase, Google Scholar, and Scopus databases from 2000 to Oct 2020. Nineteen studies were selected based on the inclusion criteria and analysis by Comprehensive Meta-Analysis.

    Results

    Based on the data analysis, The rates of antibiotic resistance in animal strains were as follows: Flumequine (75.1%), Enrofloxacin (55.2%), Danofloxacin (48.1%), Ciprofloxacin (48.4%), and Norfloxacin (52.9%). Next, the rates of quinolone resistance among E. coli strains isolated from animal products were Norfloxacin (45.5%), Ciprofloxacin (44.5%), and Enrofloxacin (60.9%). Based on the funnel plots and Egger's test, there was no significant publication bias.

    Conclusion

    We finally concluded that antibiotic resistance in commensal E. coli is related to the overuse of antibiotics in livestock, especially fluoroquinolones.

    Keywords: Animal Products, Antimicrobial Resistance, Escherichia Coli, Fluoroquinolones, Iran
  • Abhishek Mehta*, Dharmendra Singh Gurjar, Vijay Singh Rajak
    Background & Aims

    Urinary tract infections (UTI) are a leading cause of bacterial infections in humans.The widespread use of antibiotics has resulted in the emergence of antibiotic-resistant microorganisms. Hence, the current study was conducted to investigate the antibiotic sensitivity pattern of uropathogens in UTI.

    Materials & Methods

    A total of 642 urine samples were collected from suspected UTI patients and tested microbiologically. Antimicrobial susceptibility tests were performed for the isolated pathogens using the Kirby- Bauer disk diffusion method.

    Results

    Out of 642 urine samples, 308 (48%) were found to exhibit significant bacteriuria. Females had a higher rate of UTI (68%) than males (32%), with a higher prevalence in the middle-aged group, while males reported a higher prevalence in the elderly group, which was statistically significant. The most common organism was Escherichia coli (57.2%), followed by Klebsiella pneumoniae (26.3%), Pseudomonas aeruginosa (8.4%), Proteus spp. (3.6%), Enterococcus spp. (2.6%), and Staphylococcus aureus (1.9%). UTI were more common in middle-aged female patients (31 to 45 years), while in males, high prevalence was seen in older patients (>45 years). Meropenem, Gentamicin, Nitrofurantoin, and Co-Trimoxazole were amongst the most sensitive drugs against E.coli and K.pneumoniae.

    Conclusion

    Due to the irrational and injudicious use of antibiotics, commonly isolated uropathogens have a changing resistance pattern, resulting in reduced treatment effectiveness. This could be overcome by routine antimicrobial resistance surveillance, antimicrobial stewardship measures, and culture-guided therapy.

    Keywords: Antibiotic Susceptibility Pattern, Antimicrobial Resistance, Bacteriuria, Escherichia Coli, Urinary Tract Infection, Uropathogens
  • پریسا نوربخش، تقی صالحی زهرایی، سامان حسینخانی، جلیل مهرزاد*
    مقدمه

    مقاومت آنتی بیوتیکی به طور نگران کننده ای در حال افزایش است. اخیرا استفاده از پست بیوتیک ها علیه عوامل میکروبی پاتوژن برای فرموله کردن داروهای جدید همراه یا جایگزین آنتی بیوتیک ها مد نظر قرار گرفته است. به این ترتیب، پژوهش حاضر با هدف بررسی اثرات بازدارندگی پست بیوتیک لاکتوباسیلوس پاراکازئی بر رایج ترین پاتوژن های استافیلوکوکی و کلی فرمی انجام گرفت.

    روش کار

    سویه استاندارد باکتری لاکتوباسیلوس پاراکازئی در محیط MRS کشت داده شد. سپس اثر مهاری پست بیوتیک های بدست آمده و کنترلهای منفی (بدون تیمار) و مثبت (تیمار با آنتی بیوتیک بر دو باکتری پاتوژن استافیلوکوک اورئوس و اشرشیا کلی توسط تست MIC به روش رقیق سازی در پلیت های 96 چاهکی ارزیابی شد. نتایج در طول موج 630 نانومتر خوانش شد.

    یافته ها

    اثر همه پست بیوتیک ها به جز گروه C (مایع رویی بدست آمده دارای تیمار سونیکاسیون- شوک حرارتی) نسبت به کنترل منفی (بدون تیمار) معنادار بود (p<0.05). پست بیوتیک گروهD)مایع رویی بدست آمده دارای تیمار سونیکاسیون - شوک حرارتی- فریز و دفریز) بطور چشمگیری مثل کنترل مثبت (تیمار با آنتی بیوتیک مروپنم) رشد استافیلوکوکوس اورئوس (P=0.0006) و اشریشیا کلی (P=0.0003) مهار کرد. همچنین گروه های مختلف پست بیوتیک تاثیر تقریبا مشابه غیر معنا داری بر پاتوژنهای استافیلوکوکی در مقایسه با کلی فرمی داشتند.

    نتیجه گیری

    یافته های این پژوهش بر پتانسیل ضد باکتریای پست بیوتیک های لاکتوباسیلوس پاراکازئی علیه پاتوژن های رایج تاکید می کند، و آنها را برای توسعه و کاربردهای بیشتر زیست پزشکی و دارویی نامزدهای امیدوارکننده ای مینماید.

    کلید واژگان: استافیلوکوک, کلی فرم, پستبیوتیک, لاکتوباسیلوسف, آنتی بیوتیک
    Parisa Nourbakhsh, Taghi Zahraei Salehi, Saman Hosseinkhani, Jalil Mehrzad *
    Introduction

    Antibiotic resistance is regrettably increasing. Recently, application of postbiotics against various microbial pathogens can safely be considered to formulate/substitute with antibiotics. As such, we aimed to investigate the inhibitory effect of Lactobacillus Paracasei against the most common Staphylococcal and coliform pathogens.

    Methods

    The standard strain of Lactobacillus (L.) paracasei was cultivated in MRS medium. Then, the inhibitory effects of different obtained postbiotics along with negative-and-positive controls on two pathogenic bacteria, Staphylococcus (S.) aureus and Escherichia (E.) coli, was evaluated by the MIC test using the microdilution method on 96-well plates. The results were determined at 630 nm.

    Findings

    The effect of all isolated postbiotics except group C (supernatant obtained with sonication-heat shock treatment) compared to the negative controls (without treatment) was statistically significant (p<0.05). Also, the postbiotic group D (supernatant obtained with sonication-thermal shock-freeze treatment) had as remarkably inhibitory effect as positive control (with meropenem treatment) on S. aureus (p=0.0006) and E. coli (P=0.0003). Also, different groups of postbiotics had almost similarly non-significant effect on S. aureus versus E. coli.

    Conclusion

    Results of this study emphasize the antibacterial potential of Lactobacillus paracasei postbiotics against common pathogens, and these postbiotics can be considered as one of the promising candidates for development and further biomedical and pharmaceutical applications.

    Keywords: Staphylococcus Aureus, Escherichia Coli, Postbiotic, Lactobacillus Paracasei, Antibiotic Resistance
  • هادی نیک نژاد، نیما کلوانی، مهدی سیدی راد، علیرضا اعلا، رضا سعیدی، مهرنوش ابطحی، فتح الله غلامی بروجنی*
    زمینه و هدف

    نگرانی هایی در مورد آلودگی میکروبی در شهرهای ساحلی شمال کشور بویژه شهرهای استان مازندران وجود دارد که می تواند خطراتی را برای سلامتی شناگران و گردشگران به همراه داشته باشد. مطالعه حاضر با هدف بررسی کمی میزان خطر بروز بیماری های گوارشی ناشی از مواجهه با باکتری های اشرشیا کلی (E.coli) و انتروکوکوس در حین فعالیت های تفریحی در سواحل فریدونکنار انجام شد.

    روش بررسی

    در مطالعه توصیفی مقطعی حاضر، به منظور بررسی وضعیت میکروبی شناگاه های ساحلی فریدونکنار 66 نمونه بصورت لحظه ای در فصل تابستان برداشت شد. روش شبیه سازی مونت کارلو برای محاسبه خطر عفونت روزانه و سالانه مورد استفاده قرار گرفت.

    یافته ها

    نتایج نشان داد که در آب های تفریحی این سواحل، خطر ابتلا به انتروکوکوس بیشتر از E.coli بود. میانگین خطر عفونت سالانه E.coli در بزرگسالان و کودکان به ترتیب 0/41 و 0/69 بود. همچنین خطر عفونت سالانه انتروکوکوس برای کودکان و بزرگسالان 1 و 0/99 بود که بالاتر از سطح توصیه شده توسط WHO و EPA بود. نتایج نشان داد که خطر ابتلا به عفونت برای کودکان بیشتر از بزرگسالان بوده است.

    نتیجه گیری

    تخلیه کنترل نشده فاضلاب های شهری و صنعتی به دریاها و رودخانه ها نقش اساسی در آلودگی میکروبی سواحل دارد. با اجرای استراتژی های مدیریت زیست محیطی و تفریحی موثر، می توان خطرات بهداشت عمومی را در سواحل تفریحی به حداقل رساند و در عین حال زیبایی طبیعی این فضاهای عمومی مهم را نیز حفظ کرد.

    کلید واژگان: شناگاه های ساحلی, انتروکوکوس, اشرشیاکلی, روش مونت کارلو
    Hadi Niknejad, Nima Kalvani, Mehdi Seyedirad, Alireza Ala, Reza Saeedi, Mehrnoosh Abtahi, Fathollah Gholami-Borujeni*
    Background and Objective

    There have been concerns about microbial contamination along the coastal cities in the north of the country, particularly in cities of Mazandaran province, which could pose health risks for swimmers and tourists. The present study aimed to quantitatively assess the risk of gastrointestinal diseases resulting from exposure to E. coli and enterococci bacteria during recreational activities on the beaches of Fereydunkanar.

    Materials and Methods

    In this cross-sectional descriptive study, 66 grab samples collected during the summer were analyzed to investigate microbial contamination in the recreational beach waters of Fereydunkanar.The Monte Carlo simulation method was used to calculate both daily and annual infection risks.

    Results

    The findings demonstrated that transmission of enterococci was more likely than that of E. coli in the swimming areas of these beaches. The average annual infection risk for E. coli was 0.41 for adults and 0.69 for children . Additionally, the annual risk of enterococci infection was 1 for adults and 0.99 children and, which exceeds the range advised by the WHO and EPA. These findings indicate that children have a higher infection risk compared to adults.

    Conclusion

    Unrestricted discharge of municipal and industrial wastewater effluents into sea and rivers can contribute to the presence of harmful microbes in beaches. By implementing effective environmental and recreational management strategies, it is possible to minimize the risk of public health hazards at recreational beaches while also preserving the natural beauty of these important public spaces.

    Keywords: Swimming Beaches, Enterococcus, Escherichia Coli, Monte Carlo Method
  • H. Seki*
    Background

    Implementing Hazard Analysis and Critical Control Point (HACCP) management across the supply chain is promoted globally to ensure the safety of marine food products due to their rapid quality deterioration. However, many seafood retail stores deviate from adopting these practices. Therefore, in this study, we aimed to create a flowchart based on HACCP and validate it in retail stores.

    Methods

    Chub mackerel (Scomber japonicus), scallops (Patinopecten yessoensis), and whiteleg shrimp (Litopenaeus vannamei) specimens were purchased from a supermarket from August to December 2020. The handling information of these products from receipt to sales was obtained to prepare an HACCP plan for retail stores. Groups adhering to and deviating from flowchart conditions were categorized as Critical Control Point (CCP)-compliant and CCP-deviant, respectively. Four samples of each product for each condition were analyzed. Bacterial viability was evaluated using the flat agar culture method. Escherichia coli and Vibrio parahaemolyticus were detected using the Brilliant Green-Lactose-Bile and material point methods, respectively. Product freshness was assessed by determining K-values using High-Performance Liquid Chromatography. Results were compared using Student’s t-test.

    Results

    At elevated storage temperatures, bacterial growth rates were higher in chub mackerel and whiteleg shrimp than those in scallops. E. coli was not detected in any sample, whereas V. parahaemolyticus was detected in scallops and whiteleg shrimp but not in chub mackerel. CCP-deviant refrigerated scallops had increased V. parahaemolyticus counts; however, it did not differ between the frozen scallop and whiteleg shrimp. K-values increased more rapidly in CCP-deviant chub mackerel, whiteleg shrimp, and refrigerated scallops, but not in frozen scallops. Inadequate temperature control during display and sale markedly deteriorated the quality of marine products.

    Conclusion

    Setting CCPs for marine food product display and sale while controlling temperature can preserve product quality. The flowchart created in this study can be broadly used for marine retail stores.

    Keywords: Microbial Viability, Escherichia Coli, Seafood, Hazard Analysis, Critical Control Points, Food Safety
  • Y.Y. Varela-Rangel, L. Guillén, C. Cuadra-Sánchez, M. Araque*
    Background

    Fresh pasta filata cheese is considered as one of the most important foods in the Venezuelan diet. It is typically produced by small-scale producers using raw milk. The objective of this research was to molecularly characterize the pathogenic potential of Escherichia coli strains isolated from pasta filata cheese manufactured and marketed in Venezuela.

    Methodology

    In the period between January and March of 2019, a total of 36 strains of E. coli were isolated from a variety of pasta filata cheeses including 17 samples of mozzarella, 16 of telita, and 3 of guayanés. These strains were isolated according to the Venezuelan Commission of Industrial Standards (COVENIN) and identified by conventional methods (biochemical and phenotypic tests). Antimicrobial susceptibility was determined using the disk diffusion technique. Phylogenetic grouping and detection of virulence genes were performed by Polymerase Chain Reaction amplification. Diversity and genetic relationships were determined by Rep-PCR.

    Results

    All strains were susceptible to the tested antibiotics. Phylogroup A (n=19) was the most frequent (52.8%), followed by groups D (n=11; 30.6%), and B1 (n=2; 5.6%). The majority of isolates carried at least two virulence genes, one coding for adhesion mechanisms (fimH) and the other for iron uptake (fyuA). Only one strain of phylogroup A presented a profile consisting of four virulence genes (fimH, fyuA, kpsMT II, and papAH). Four strains that could not be classified according to Clermont's scheme carried resistance genes as well. A heterogeneous population structure was observed by Rep-PCR of the strains.

    Conclusion

    Results support the hypothesis that the E. coli strains isolated from the three types of pasta filata cheeses manufactured and marketed in Venezuela have identical characteristics and virulence factors to Extraintestinal Pathogenic E. coli strains observed in animals and humans, posing a potential health risk. Therefore, it is essential to improve hygienic and sanitary controls at all stages of cheese production and to implement measures for epidemiological surveillance of potentially pathogenic bacterial strains present in Venezuelan, artisanal pasta filata cheeses.

    Keywords: Escherichia Coli, Food Safety, Cheese, Virulence, Genetic Variation
  • Bahman Mirzaei*
    Background & Objective

    Extended-spectrum beta-lactamases (ESBLs) are enzymes in bacteria that resist many antibiotics. Detection of ESBLs production is important as it's a marker of colonization and potential transfer to other patients. We studied the antibiotic susceptibility, biofilm formation capacity, and prevalence of ESBLs of opportunistic bacteria including K. pneumoniae and E. coli. The isolates capable of biofilm formation were analyzed among 100 E. coli and 104 K. pneumoniae isolates.

    Materials & Methods

    This process involved collecting and identifying bacterial samples, testing antibiotic susceptibility, detecting ESBLs phenotypes, and multidrug-resistance (MDR) isolates, assessing biofilm formation capability, and evaluating results through statistical analysis.

    Results

    The susceptibility tests for discs were performed following the guidelines outlined by the Clinical Laboratory Standards Institute in 2023 (CLSI). K. pneumoniae exhibits inherent resistance to ampicillin, while 80 (80%) strains of E. coli have been reported to be resistant to ampicillin. Additionally, 50 K. pneumoniae isolates and 41 E. coli isolates were found capable of forming a biofilm. Seven of E. coli (17.07%), and seven of K. pneumoniae (14%) isolates could form a mighty biofilm. It was observed that the strongest resistance in the isolates that formed strong biofilm was related to tetracycline with 5 (7.2%) resistance in K. pneumonia and 7 (7%) resistance in E. coli. Furthermore, 47 (47%) of E. coli, and 21 (20.2%) of K. pneumoniae isolates were classified as ESBLs producers, and 52 (50%) K. pneumoniae and 72 (72%) E. coli isolates were classified as MDR.

    Conclusion

    Considering the role of biofilm in the transfer of genes, appropriate health policies, and the correct administration of effective antibiotics can help in prevention.

    Keywords: Escherichia Coli, Klebsiella Pneumoniae, Antibiotic-Resistant, Biofilm, Esbls, MDR
  • Hossein Golchinpour, Alireza Momeni, Mohammadhadi Meshkatalsadat *

    The green synthesis of metal oxide nanoparticles using plant extracts can effectively replace traditional chemical synthesis methods. In present paper, we describe the formation of zinc oxide (ZnO) nanoparticles (NPs) using Pistacia vera soft peel extract. Synthesis of plant-based nanoparticles possesses numerous advantages compared to the conventional physicochemical approaches with different applications in biology and medicine. In the present study Pistacia vera peel extract was used to synthesize ZnO NPs. To investigate the optical and structural features of ZnO nanoparticles synthesized by Pistacia vera peel extract, X-ray diffraction (XRD), Fourier transform infrared (FTIR) spectroscopy, ultraviolet-visible spectrophotometer (UV-Vis), and scanning electron microscope (SEM) were used. The off-yellow hue of the reaction mixture indicated that ZnO NPs were formed. The presence of Pistacia vera peel extract-mediated ZnO NPs was revealed by UV-Visible peaks at 422 nm. In addition, an XRD pattern confirmed the formation of spherical structure nanomaterials with an average size of 42 nm along with the XRD pattern matching the JCPDS card. The Existence of bioactive functional groups effective in reducing the bulk of zinc sulfate to ZnO NPs was further confirmed by FTIR. The SEM images revealed the spherical shape, and the size of nanoparticles, which was within the range of 31.14 to 48 nm. To examine the antibacterial potential of ZnO NPs, a paper disc diffusion technique was used against Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus clinical strains in terms of the inhibition zone. In addition, the radical scavenging assay was done by the DPPH test. The green synthesized Pistacia peel extract-mediated ZnO NPs demonstrate striking antioxidative activity at 100 μg mL–1. Using NaBH4, nanoscale zinc oxide can remove methylene blue in only 150 seconds. Furthermore, they remove 98% of methylene blue in 14 minutes under UV light.

    Keywords: Antibacterial, Antioxidant, Dye Reduction, Green Synthesis, Escherichia Coli, Staphylococcus Aureus
  • Mozhgan Fateh, Fatemeh Forohi*, Fatemeh Rafiee
    Background & Objectives

    Urinary tract infection (UTI) is a serious issue affecting both men and women resulting from the invasion of microbial agents into the urinary system. This study aimed to investigate the antimicrobial activity of Lactobacillus casei (L. casei) against Klebsiella pneumoniae (K. pneumoniae) and Escherichia coli (E. coli) isolated from UTI.

    Materials & Methods

    In this study, 100 urine specimens were obtained from medical laboratories in western Tehran. E. coli and K. pneumoniae isolates were identified and subsequently confirmed using polymerase chain reaction (PCR). Antibiotic susceptibility patterns were determined using the disk diffusion method. The antimicrobial activity of L. casei against these strains (four multidrug-resistant isolates from each species) was then evaluated using the agar well diffusion method.

    Results

    From 100 urine specimens, 76 E. coli and 14 K. pneumoniae isolates were identified. Antimicrobial susceptibility testing revealed that imipenem and nitrofurantoin were the most effective antibiotics against E. coli, while amikacin demonstrated the highest efficacy against K. pneumoniae. In the agar well diffusion assay, L. casei generated growth inhibition zones measuring 19.8 mm ± 3 for E. coli and 20.3 mm ± 4 for K. pneumoniae.

    Conclusions

    Lactobacillus casei demonstrates notable antimicrobial efficacy against both E. coli and K. pneumoniae, suggesting its potential as an alternative therapeutic option for UTIs.

    Keywords: Lactobacillus Casei, Escherichia Coli, Klebsiella Pneumoniae, Urinary Tract Infection, Probiotics
  • شایان صفوی، ملیکا پیمان گهر، محدثه خاکپور، فاطمه فردصانعی، فرهاد نیکخواهی*

    پیش زمینه و هدف :

    اشریشیا کلی و کلبسیلا پنومونیه باکتری های مهم ایجادکننده عفونت های بیمارستانی هستند که با کسب پلاسمیدهای کدکننده بتالاکتامازها به آنتی بیوتیک های بتالاکتام مقاوم شده اند. مقاومت به مواد ضدعفونی کننده در این سویه ها نیز مشاهده شده است. بنابراین هدف انجام این مطالعه بررسی اثر ضدمیکروبی ماده ضدعفونی کننده کلرهگزیدین بر روی سویه های اشریشیا کلی و کلبسیلا پنومونیه مقاوم به چند دارو بود.

    مواد و روش کار

    نمونه ها از بخش ICU بیمارستان های شهر قزوین جمع آوری شدند. تمامی ایزوله ها به روش فنوتایپی موردبررسی قرار گرفتند. اثر کلرهگزیدین بروی سویه های انجام شد.

    یافته ها

    از 70 ایزوله اشریشیا کلی 45 ایزوله MDR بودند و از 74 ایزوله کلبسیلا پنومونیه 3/83 بود. تمامی نمونه دارای حساسیت یکسان به کلرهگزیدین بودند. EDTA اثر هم افزایی بر این دو ماده نداشت.

    بحث و نتیجه گیری

    نتایج مطالعه ما نشان داد که کلرهگزیدین به طور موثری می تواند سویه های اشریشیا کلی و کلبسیلا پنومونیه تولیدکننده و غیر تولیدکننده بیوفیلم را از بین ببرد. بنابراین در غلظت های پایین از این ماده ضدعفونی کننده می توان در جهت کنترل مقاومت های آنتی بیوتیکی در باکتری اشریشیا کلی و کلبسیلا پنومونیه مقاوم به چند دارو در عفونت های بیمارستانی استفاده کرد.

    کلید واژگان: کلرهگزیدین, بتالاکتاماز, اشریشیا کلی, کلبسیلا پنومونیه
    Shayan Safavi, Melika Peyman Gohar, Mohadeseh Khakpour, Fatemeh Fardsanei, Farhad Nikkhahi*
    Background & Aims

    Escherichia coli and Klebsiella pneumoniae are important bacteria that cause hospital-acquired infections and have become resistant to beta-lactam antibiotics through the acquisition of beta-lactamase-encoding plasmids. Resistance to disinfectants has also been observed in these strains. Therefore, the aim of this study was to investigate the antimicrobial effect of the disinfectant chlorhexidine on multidrug-resistant strains of Escherichia coli and Klebsiella pneumoniae.

    Materials & Methods

    Clinical samples were collected from the intensive care unit of Qazvin hospital. All isolates were analysed by phenotypic method. Finally, the combined effect of chlorhexidine and EDTA on the collected strains was performed.

    Results

    45% of the 70 Escherichia coli isolates were MDR and 83.3% of the 74 Klebsiella pneumoniae isolates. All samples were equally sensitive to chlorhexidine. EDTA showed no synergistic effect with this substance.

    Conclusion

    The results of our study show that chlorhexidine can effectively destroy Escherichia coli and Klebsiella pneumoniae producing and non-producing biofilm strains. Therefore, this disinfectant can be used at low concentrations to control antibiotic resistance in multidrug-resistant Escherichia coli and Klebsiella pneumoniae bacteria in hospital-acquired infections.

    Keywords: Chlorhexidine, Beta-Lactamase, Escherichia Coli, Klebsiella Pneumoniae
  • Mohammad Bahloli, Hossein Samadi Kafil, Parisa Roshani Asl, Niloufar Rashidi*, Seyyed Reza Moaddab*
    Background

     Escherichia coli is one of the main causes of various diseases worldwide, whose multidrug-resistant strains have caused many public health problems by producing extended-spectrum β-lactamases (ESBLs). The resistance rate varies in different regions. Thus, it is necessary to identify ESBL-producing strains in each region and their antibiotic sensitivity in order to find appropriate treatment options. Hence, the present study aimed to detect the ESBL-producing E. coli strains and their antimicrobial susceptibility pattern in Tabriz, Iran.

    Methods

     This study was conducted at the Imam Reza Hospital in Tabriz from November 20, 2022, to April 20, 2023. A total of 400 E. coli isolates were collected from different clinical specimens. Antimicrobial susceptibility testing was performed by the disk diffusion method. ESBL-producing isolates were detected by the double-disc synergy test method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines.

    Results

     Out of 400 E. coli isolates, 211 (52.75%) were obtained from females, and 189 (47.25%) belonged to males. The mean age of patients was 52.1±27.9 years. Overall, 279 (69.75%) were confirmed as ESBL producers. These producers were mainly recovered from outpatients. The highest antibiotic resistance was observed to ceftriaxone (86.25%) and tetracycline (80.75%), and the least antibiotic resistance was related to imipenem (8%) and amikacin (16.25%), respectively. The rate of antibiotic resistance among ESBL producers was higher than among non-ESBLs.

    Conclusion

     The present study reported a high prevalence of ESBL-producing E. coli among patients referring to Imam Reza hospital in Tabriz. Carbapenems, aminoglycosides, and nitrofurantoins were confirmed as the most efficient drugs for these bacteria, whereas cephalosporins, fluoroquinolones, and sulfonamides were the least effective agents.

    Keywords: Escherichia Coli, Antibiotics, Antimicrobial Susceptibility, Extended-Spectrum Β-Lactamase
  • Seyyed Jalil Mousavi *, Rahim Nejadrahim, Farima Abdulzadeh
    Background & Objective

    Hospital-acquired infections (HAIs) are a major healthcare problem in hospitalized patients, especially in developing countries, where they affect millions of patients and cause high mortality rates. This study aimed to investigate multidrug-resistant bacterial strains in NIs at Imam Khomeini University Hospital in Urmia, Iran.

    Methods

    This cross-sectional study was conducted using a convenience sampling method. The study population comprised all positive clinical samples from HAIs registered in the laboratory of Imam Khomeini Hospital, Urmia, Iran, in 2019. Bacteria were identified by culturing the samples on blood agar and MacConkey agar, followed by performing standard biochemical tests. Antibiotic susceptibility testing was carried out using the disk diffusion method, in accordance with CLSI guidelines.

    Results

    Of the 607 positive samples, the most common microorganisms isolated were Escherichia coli (27.5%), Acinetobacter baumannii (18.5%), and Klebsiella pneumoniae (15.2%). The distribution of resistance to the number of antibiotics in bacterial isolates from the samples showed that 19.8% of them were resistant to one antibiotic and 13.2% were resistant to three antibiotics. 40.5% of the samples showed no resistance to antibiotics.

    Conclusion

    This study highlights the critical issue of HAIs and the prevalence of multidrug-resistant bacteria in Urmia, Iran. Urgent measures, including improved hygiene, accurate diagnostics, appropriate antibiotic use, and stakeholder education, are essential. Establishing a robust HAI surveillance system is also recommended. Future efforts should aim at understanding and mitigating the spread of these pathogens.

    Keywords: Drug Resistance, Escherichia Coli, Nosocomial Infections, Prevalence
  • Mohsen Meidani, Sepideh Zahak Miandoab, Amir Salami, Sajedeh Jadidi, Marjan Sohrabi, Parvaneh Ebrahimi Alavijeh, Sara Ghaderkhani, Hamid Emadi Koochak, Arezoo Salami Khaneshan *
    Background and Objectives

    To explore the prevalence and characteristics of secondary bacterial infections among patients suffering from mucormycosis following COVID-19 infection.

    Materials and Methods

    We conducted a cross-sectional, retrospective analysis from March 2020 to April 2022 at Imam Khomeini Hospital Complex in Tehran. The study included patients with histopathologically confirmed mucormycosis and documented secondary bacterial infections. We extracted and analyzed data from hospital records using SPSS software, version 26.

    Results

    The study comprised 27 patients, with a predominance of females (70.4%) and an average age of 56 years. The majority of these patients (63%) had pre-existing diabetes mellitus. The severity of their COVID-19 infections varied. Treat- ment regimens included immunosuppressive drugs and antibiotics. Rhinocerebral mucormycosis was the most common form observed. The predominant secondary infections involved the urinary tract, respiratory system, bloodstream (bacteremia), and soft tissues, with resistant strains of Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae being the most frequently identified microorganisms. Notably, cases of bacteremia and pneumonia exhibited a higher mortality rate. Ultimately, 55.6% of patients were discharged, while 44.4% succumbed to their infections.

    Conclusion

    Patients recovering from COVID-19 with mucormycosis are significantly susceptible to secondary bacterial infections, particularly those with diabetes mellitus or those undergoing immunosuppressive therapy. Such infections com- pound the morbidity and mortality risks in this vulnerable patient cohort.

    Keywords: Bacterial Infection, Mucormycosis, COVID-19, Acinetobacter Baumannii, Klebsiella Pneumonia, Escherichia Coli
  • Atul Arya, Suresh Kumar *, Dolly Kain, Vandana Vandana, Khaling Mikawlrawng
    Introduction

     Drymaria cordata is used traditionally against hyperglycemia. In this research the methanol (DCM), hexane (DCH), and water (DCW) extracts of D. cordata were investigated for their metabolite profiling, antioxidant, antibacterial, and carbohydrate hydrolyzing enzyme inhibitory activities.

    Methods

     The antidiabetic activities of the extracts were investigated using the α-amylase and α-glucosidase (carbohydrate-hydrolyzing enzymes) inhibition assays and yeast glucose uptake assays. Antibacterial investigation of D. cordata extracts was done against methicillin-resistant Staphylococcus aureus (MRSA) and β-lactam-resistant Escherichia coli. The zone of inhibition and minimum inhibitory concentration (MIC) were observed.

    Results

     GC-MS metabolite profiling revealed the presence of stearyl aldehyde, henicosanal, glycidyl palmitate, eicosane, phytol, octacosanal, and neophytadiene. The DCM extract had a higher phenolic (168.19 ± 3.34 mg gallic acid equivalent/g), flavonoid (843 ±11.55 mg rutin equivalents/g), and ferric reducing potential (556.083 ± 6.51 mg ascorbic acid equivalent/g) than the DCH and DCW extracts. Also, DCM showed its greatest scavenging activity with a minimum IC50 value using the ABTS assay. DCM extract had the highest zone of inhibition and lowest MIC value against E. coli and S. aureus. Carbohydrate-hydrolyzing enzymes were inhibited, with DCM extract having minimum IC50 values of 714.66 µg/ml and 508.94 µg/ml. Yeast glucose uptake assays confirmed the highest efficacy of DCM extract for glucose uptake by yeast cells.

    Conclusion

     Drymaria cordata, especially DCM, has the potential to be considered an effective phytopharmaceutical drug for the treatment of oxidative stress, bacterial infections, and type 2 diabetes.

    Keywords: Α-Amylase, Α-Glucosidase, Free Radicals, Staphylococcus Aureus, Escherichia Coli, Yeast Cells
  • Shaymaa Abdulrahman, Farokh Rokhbakhsh Zamin *, Ashraf Kariminik
    Biofilm is a community of bacteria surrounded by extracellular polymeric substances, providing protection against harsh environmental conditions and serving as a major cause of various infections. The objective of this study was to evaluate the effects of various antibiotics on Escherichia coli biofilms obtained from nosocomial infections, as well as to explore the correlation between virulence factors and the formation of biofilms.A total of 140 Escherichia coli isolates from nosocomial infections were analyzed for antibiotic susceptibility using the Kirby-Bauer method. Biofilm formation was assessed using the crystal violet microplate technique, with a focus on identifying biofilm-associated genes such as afa, pap, sfa, agg, and fimH. Based on CLSI criteria, Imipenem exhibited the highest sensitivity at 99.28%, whereas Cotrimoxazole showed the highest resistance at 91.43%. Among the isolates, 41.43% did not form biofilms, while 21.43%, 19.29%, and 17.85% formed weak, moderate, and strong biofilms, respectively. A correlation was found between biofilm formation and antibiotic resistance. The frequency of fimH, Pap, Sfa, afa, and agg genes among the isolates was 59.28%, 26.42%, 17.85%, 8.57%, and 0.00%, respectively. The study suggests that high antibiotic resistance may be associated with strong or moderate biofilm production. The ability of E. coli strains to form biofilms may play a crucial role in managing nosocomial infections.
    Keywords: Escherichia Coli, Biofilm Producing Genes, Antibiotic Resistance
  • آرش جمالزاده، محدثه خاکپور، فاطمه فرد صانعی، فرهاد نیکخواهی*
    پیش زمینه و هدف

    باسیل گرم منفی اشریشیا کلی یکی از شایع ترین عوامل اتیولوژیک عفونت های دستگاه ادراری است. مطالعات متعددی نشان داده اند که آنتی بیوتیک فسفومایسین، با مکانیسم اثر مهار ساخت پپتیدو گلیکان، اثر مهاری قابل توجهی بر روی پاتوژن های گرم منفی ازجمله اشریشیا کلی دارد. بنابراین این مطالعه، باهدف درک بهتر اثرات فسفومایسین در برابر اشریشیا کلی مقاوم به چند دارو ایجادکننده عفونت های ادراری انجام شده است.

    مواد و روش کار

    در این مطالعه اپیدمیولوژی -توصیفی، 90 جدایه اشریشیا کلی در فاصله زمانی مهرماه 1401 تا مهرماه 1402 از نمونه های ادراری بیمارستان های آموزشی شهر قزوین، جمع آوری شد که پس از تعیین هویت، تست حساسیت آنتی بیوتیکی به روش دیسک دیفیوژن انجام شد. شناسایی سویه های تولیدکننده ESBL و AmpC به روش فنوتایپی صورت گرفت. داده ها با استفاده از نرم افزار SPSS نسخه 2022 با سطح معناداری کمتر از 05/0 مورد ارزیابی و بررسی قرار گرفت.

    یافته ها

    از میان 90 ایزوله اشریشیا کلی، بیشترین مقاومت آنتی بیوتیکی به ترتیب برای آمپی سیلین (6/96درصد)، سفوتاکسیم (90درصد) و سفتازیدیم (4/84درصد) و بیشترین حساسیت مربوط به آنتی بیوتیک های فسفومایسین (9/98درصد)، مروپنم (8/98درصد)، جنتامیسین (8/88درصد) و نیتروفورانتوئین (4/84درصد) بود.

    بحث و نتیجه گیری

    با افزایش مقاومت آنتی بیوتیکی و همچنین گسترش سویه های تولیدکننده آنزیم های بتالاکتاماز، درمان عفونت های ایجادشده توسط این سویه ها با مشکل جدی روبه رو شده است. در این مطالعه با بررسی حساسیت ایزوله های اشریشیا کلی تولیدکننده بتالاکتامازهای وسیع الطیف و مقاوم به چند دارو نسبت به فسفومایسین، مشاهده شد که 89 (9/98درصد) جدایه، به فسفومایسین حساس بودند که نشان دهنده این است که فسفومایسین یک آنتی بیوتیک موثر برای ایزوله های ESBL در کشور ایران است.

    کلید واژگان: اشریشیا کلی, فسفومایسین, بتالاکتاماز های وسیع الطیف
    Arash Jamalzadeh, Mohadeseh Khakpour, Fatemeh Fardsanei, Farhad Nikkhahi*
    Background & Aims

    Escherichia coli, a gram-negative bacillus, is one of the most common pathogens causing urinary tract infections. Several studies have demonstrated that the antibiotic fosfomycin has a significant inhibitory effect on Gram-negative pathogens, including Escherichia coli, by inhibiting peptidoglycan production. This study aimed to better understand the effect of fosfomycin against multidrug-resistant Escherichia coli causing urinary tract infections.

    Materials and Methods

    In this epidemiologic-descriptive study, 90 Escherichia coli isolates were collected between October 1401 and October 1402 from urine samples of teaching hospitals in Qazvin city. ESBL- and AmpC-producing strains were identified using the phenotypic method. Data were evaluated and analyzed using SPSS software version 2022 with a significance level of less than 0.05.

    Results

    Among the 90 isolates of Escherichia coli, the highest antibiotic resistance was observed for ampicillin (96.6%), cefotaxime (90%), and ceftazidime (84.4%), while the highest susceptibility was related to the antibiotics fosfomycin (98.9%), meropenem (98.8%), gentamicin (88.8%), and nitrofurantoin (84.4%).

    Conclusion

    With the increase in antibiotic resistance and the spread of strains producing beta-lactamase enzymes, the treatment of infections caused by these strains has become a serious problem. In this study, the susceptibility of Escherichia coli isolates that produce broad-spectrum beta-lactamases and are resistant to multiple drugs to fosfomycin was investigated. It was found that 89 (98.9%) isolates were sensitive to fosfomycin, indicating that fosfomycin is an effective antibiotic against ESBL isolates in Iran.

    Keywords: Escherichia Coli, Fosfomycin, Broad-Spectrum Beta-Lactamases
  • Mohammadmehdi Soltan- Dallal*, Seyedeh Zohre Mirbagheri, Saeed Vahedi, Mohammadreza Mohammadi, Hedroosha Molla Agha Mirzaei
    Background and Objective

    Investigating multidrug resistance and TEM and SHV broad-spectrum beta-lactamase genes in Escherichia coli bacteria isolated from patients with urinary tract infections is very useful to improve the treatment of infection and prevent the failure of treatment of urinary tract infections.The aim of this study was to investigate multidrug resistance and TEM and SHV broad-spectrum beta-lactamase genes in Escherichia coli bacteria isolated from patients with urinary tract infections.

    Materials and Methods

    In this study, 188 strains of Escherichia coli, which cause urinary tract infections in Alborz province, were studied. Urine samples were cultured on EMB and Blood Agar media. Differential tests were performed for final identification. ESBL-producing strains were identified, PCR was performed to survey the abundance of ESBL-producing genes.

    Results

    Based on the results of the disk diffusion and Double-disk synergy testS, 82 (43.6%) strains were determined as the final producer of ESBL. out of these isolates, the frequency of SHV, TEM, and CTX genes measured 64.3%, 55.9%, and 21.4%, respectively. These results showed that 12 (14.28%) of Escherichia coli isolated have all genes, 26 (30.95%) had 2 genes and 36 (42.85%) had one gene.

    Conclusion

    According to the results, it was found that imipenem with the lowest resistance is the best drug in the treatment, and carbapenems are the best drug for treating diseases caused by Escherichia coli. The results of the current study may be useful in replacing ESBL enzyme resistance screening with more modern sensitivity measurement methods such as MIC and Etest.

    Keywords: Escherichia Coli, Drug Resistance, Beta-Lactamases, Extended-Spectrum Beta-Lactamases (Esbls)
  • علیرضا شعبانی، علی اکبر شعبانی*، رضا نصر، مریم اردکانیان، سیما روایی، علیرضا افغان پرتابی، حسین عنانی، هدی شعبانی، علی ابوذری، مجید قربانی، فاطمه مهرجو
    هدف

    گزارشات متعددی، حاکی از شیوع مقاومت های چندگانه دارویی با واسطه انواع مختلف(ESBL Lactamases Extended Spectrum Beta) از جمله آنزیم های حاصل از بیان ژن SHV در نقاط مختلف دنیا  موجود می باشد، که یکی از معضلات عمده درمانی و پزشکی می باشد. امروزه، بررسی نقش باکتری اشریشیاکلی در انواع عفونت ها از جمله عفونت های بیمارستانی، میزان استفاده از آنتی بیوتیک های مختلف در درمان، با توجه به افزایش روز افزون مقاومت باکتری های عامل عفونت در برابر آنتی بیوتیک ها یک ضرورت است. هدف از اجرای این طرح پژوهشی، بررسی میزان شیوع ژن SHV به عنوان یکی از ژن های کد کننده  ESBL در باکتری های مولد عفونت  ازجمله در سویه های E. coli بود.

    مواد و روش ها

    نمونه برداری و جداسازی اشریشیاکلی از نمونه های جمع آوری شده از مراجعین مشکوک به عفونت ادراری با استفاده از روش های استاندارد و آزمون آنتی بیوگرام با استفاده از روش دیسک- دیفیوژن بر روی آن ها انجام شد. به منظور تشخیص قطعی تولید آنزیم های بتالاکتاماز وسیع الطیف (ESBLs) با استفاده از زوج دیسک های آنتی بیوتیکی سفتازیدیم، سفوتاکسیم، سفوتاکسیم، و سفتازیدیم/ با و بدون کلاوولانیک اسید خریداری شده از شرکت Mast انگلیس مورد آزمون قرار گرفتند. با استخراج DNA از آن ها و با استفاده از پرایمرهای اختصاصی طراحی، ارزیابی و تهیه شده برای ژن SHV و انجام PCR وجود و یا فقدان ژن SHV در سویه های فوق، مورد ارزیابی قرار گرفت. نتایج با استفاده ازآزمون آماری مجذور کای (2×، chi-square) و نرم افزار 16spss آنالیز گردید.

    یافته ها

    سویه های باکتری E. coli از 151 نمونه ایزوله ادراری (75/37%) جدا گردید. ایزوله های مقاوم به نیتروسفین، به عنوان سویه های احتمالی تولید کننده بتالاکتامازهای وسیع الطیف (ESBLs) تلقی شدند، نتیجه آزمون فنوتیپی تائیدی، بر روی سویه های ESBL مثبت (+) احتمالی، در 33 مورد (47/67%) آن ها مثبت بود. با انجام PCR با استفاده از زوج پرایمرهای طراحی و تهیه شده برای تشخیص و شناسایی ژن SHV، نتیجه این آزمایش نیز در 9 مورد (72/72%) آن ها مثبت بود.

    نتیجه گیری

    به کارگیری روش های مولکولی در کنار روش های فنوتیپی جهت تشخیص دقیق عوامل عفونی، حتی فرم های زنده اما غیر قابل کشت آن ها (Viable but Nonculturable, VBNC) و ژن های مقاومت، می تواند کارآئی روش های "اپیدمیولوژی  مولکولی" در پیگیری و مبارزه با عفونت ها و از جمله عفونت های بیمارستانی را افزایش دهد.

    کلید واژگان: بتالاکتاماز وسیع الطیف, اشریشیاکلی, عفونت ادراری, ژن SHV
    Alireza Shabani, Ali Akbar Shabani*, Reza Nasr, Maryam Ardakanian, Sima Ravai, Alireza Afghan Pertabi, Hossein Anani, Hoda Shabani, Ali Abu Zari, Majid Qurbani, Fateme Mehrjo
    Introduction

    Numerous reports indicate the spread of multiple drug resistances through different types of Extended Spectrum Beta Lactamase (ESBL), including enzymes resulting from SHV gene expression in different parts of the world, which is one of the major medical and therapeutic problems. Nowadays, investigating the role of Escherichia coli bacteria in various infections, including hospital infections, and the amount of use of different antibiotics in treatment, considering the increasing resistance of bacteria causing infection to antibiotics, is a necessity. The purpose of this research project was to investigate the prevalence of the SHV gene as one of the genes encoding ESBL in infectious bacteria including E. coli strains.

    Materials and Methods

    Sampling and isolation of Escherichia coli collected from clients suspected of urinary tract infection using standard methods and antibiogram test using disc-diffusion method were performed on them. To identify strains producing broad-spectrum beta-lactamases (ESBLs), nitrocephene-resistant isolates rechecked with the combined disc method to definitively detect the production of broad-spectrum beta-lactamase enzymes (ESBLs) with the use of pairs of ceftazidime, cefotaxime, cefotaxime, and ceftazidime antibiotic discs with and without clavulanic acid purchased from British Mast Company were tested. By extracting DNA from them using specific primers designed, evaluated, and prepared for the SHV gene, and performing PCR, the presence or absence of the SHV gene in the above strains was evaluated.

    Results

    E. coli strains were isolated from 151 urinary samples (37.75)%. Isolates resistant to nitrocephene were considered as possible strains producing extended-spectrum beta-lactamases (ESBLs), the result of the confirmatory phenotypic test on probable positive (+) ESBL strains, in 33 cases (67.47) % of them were positive. By performing PCR using a pair of specific primers designed and prepared to detect and identify the SHV gene, the result of this test was also positive in 9 cases (72.72) % of them.

    Conclusion

    Using molecular methods along with phenotypic methods to accurately diagnose infectious agents, even their VBNC (viable but non-culturable) forms, and resistance genes can make the effectiveness of "molecular epidemiology" methods in tracking and increasing the fight against infections, including hospital infections.

    Keywords: ESBL, Escherichia Coli, Urinary Tract Infection, SHV
نکته
  • نتایج بر اساس تاریخ انتشار مرتب شده‌اند.
  • کلیدواژه مورد نظر شما تنها در فیلد کلیدواژگان مقالات جستجو شده‌است. به منظور حذف نتایج غیر مرتبط، جستجو تنها در مقالات مجلاتی انجام شده که با مجله ماخذ هم موضوع هستند.
  • در صورتی که می‌خواهید جستجو را در همه موضوعات و با شرایط دیگر تکرار کنید به صفحه جستجوی پیشرفته مجلات مراجعه کنید.
درخواست پشتیبانی - گزارش اشکال